{
  "id": 17290769,
  "title": "Thermo Fisher Scientific sr. vp Britt sells $2 million in stock",
  "url": "https://urgent.news/2026/10/30/thermo-fisher-scientific-sr-vp-britt-sells-2-million-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-30T21:15:48.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/thermo-fisher-scientific-sr-vp-britt-sells-2-million-in-stock-93CH-4988748"
  },
  "original_language": "en",
  "account": "Lisa P. Britt, Senior Vice President and Chief Human Resources Officer at Thermo Fisher Scientific Inc. (NASDAQ: TMO), divested 2,831 shares of the company's common stock on October 28, 2026. The sale occurred at a price of $706.45 per share, resulting in a total of approximately $1,999,959. The stock was trading close to its 52-week peak of $711.85 at the time, with the equity delivering a robust 48% return over the past six months. Post-transaction, Ms. Britt still directly owns 11,559.579 shares of Thermo Fisher Scientific common stock.\n\nInvestingPro analysis suggests that the stock is presently overvalued compared to its intrinsic value. Investors can gain a more comprehensive understanding of Thermo Fisher Scientific's valuation by accessing the detailed Pro Research Report, which covers this and over 1,400 other US equities. In a separate development, Thermo Fisher Scientific disclosed robust third-quarter 2026 results, surpassing market expectations. The company reported adjusted earnings per share of $6.68 and revenue of $12.14 billion, both exceeding the consensus estimates of $6.40 per share and $11.88 billion, respectively. Furthermore, Thermo Fisher achieved 6% organic growth during the quarter, leading to an upward revision of its full-year outlook for sales, profit, and cash flow.\n\nAnalysts from UBS maintained a Buy rating on Thermo Fisher Scientific, citing the strong quarterly performance and setting a price target of $800. Argus raised its price target to $780, highlighting the company's efficient capital deployment strategy, including mergers and acquisitions. Bernstein also increased its price target to $675, acknowledging Thermo Fisher's 6% organic growth, which outpaced the expected 4.2%. Additionally, Thermo Fisher announced the retirement of Executive Vice President Michael D. Shafer, effective December 31, 2026, without providing further details on Shafer's successor.",
  "summary": null,
  "key_points": [
    "Senior VP Lisa P. Britt sold 2,831 TMO shares for $2 million.",
    "Stock price near 52-week high of $711.85 at sale.",
    "Britt retains 11,559.579 TMO shares post-sale."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}